Comment on: “Safety of biologic and synthetic targeted therapies in patients with immune-mediated diseases: Data from the BIOBADAGUAY registry” Sarah Aijaz, Raveen Muzaffer

Safety of biologic and synthetic targeted therapies in patients with immune-mediated diseases: data from the BIOBADAGUAY registry Paloma de Abreu, Sonia Cabrera, Darwin Cordovilla, Lourdes Román, Cristina Brunengo, Patricia Melgarejo, Macarena Soto, Vannia Valinotti, Angelica Amarilla, Belem Acevedo, Alexis Pineda, Evelyn Leiva, Paola Pusineri, Sandra Consani, Mariela Zarza, Clyde Parodi, Zoilo Morel, Roger Rolón, Paola Jara, Raquel Aranda, Laura Martínez, Gabriela Ávila

Safety and survival associated with biologic therapies: first report of the Biobadaguay on the Paraguayan-Uruguayan registry of adverse events with biologic therapies Paloma de Abreu, Gabriela Ávila-Pedretti, Zoilo Morel, María Isabel Acosta, Sonia Cabrera-Villalba, Patricia Melgarejo, Marcos Franco, Pedro Delgadillo, Lourdes Román, Juan Gabriel Elizaur, Ernesto Paredes, Darwin Octavio Cordobilla, Daniel Palleiro, Miguel Albanese, Julio Mazzoleni